Incidence, mortality and risk factors of cervical cancer in the world
DOI:
https://doi.org/10.15419/bmrat.v4i12.386Keywords:
Cervical cancer, Incidence, Mortality, Risk factors, World, MedicineAbstract
Background: Cervical cancer imposes a huge global burden. To date, various studies have been conducted on the risk factors associated with cervical cancer. The aim of this study was to investigate the incidence, mortality, and geographical distribution of cervical cancer and its risk factors in the world.
Methods: A literature search was conducted using PubMed, Web of sciences, Scopus, and Google Scholar to search for studies published between 2000 and 2017. The keywords used included cervical cancer, cervix uteri cancer, risk factor, incidence, mortality, and a combination of these terms.
Results: The results of this study showed that the incidence of cervical cancer varies considerably between developed and developing countries. The findings of this study demonstrated that several factors including sexually transmitted infections, reproductive factors, hormonal influences, genetics and host factors are responsible for the incidence of cervical cancer.
Conclusion: The results of this review study suggested that combination of biological, economic and health factors contributes to the incidence of cervical cancer. A large proportion cervical cancer can be prevented by prevention programs, lifestyle enhancement, smoking cessation, and timely and effective treatment of pre-cancerous lesions.
References
<ol>
<li>Akinyemiju, T., Ogunsina, K., Sakhuja, S., Ogbhodo, V., & Braithwaite, D. (2016). Life-course socioeconomic status and breast and cervical cancer screening: Analysis of the WHO9s Study on Global Ageing and Adult Health (SAGE). BMJ Open, 6(11), e012753. <a href="https://doi.org/10.1136/bmjopen-2016-012753">https://doi.org/10.1136/bmjopen-2016-012753 </a></li>
<li>Al-Sherbeni, H. H., Fahmy, A. M., & Sherif, N. (2015). Predisposition to cervical atypia in systemic lupus erythematosus: A clinical and cytopathological study. Autoimmune Diseases, •••, 2015.</li>
<li>Benard, V. B., Johnson, C. J., Thompson, T. D., Roland, K. B., Lai, S. M., Cokkinides, V., . . . Weir, H. K. (2008). Examining the association between socioeconomic status and potential human papillomavirus‐associated cancers. Cancer, 113(S10), 2910–2918.<a href=" https://doi.org/10.1002/cncr.23742"> https://doi.org/10.1002/cncr.23742</a></li>
<li>Bernatsky, S., Ramsey-Goldman, R., & Clarke, A. E. (2009). Malignancy in systemic lupus erythematosus: What have we learned? Best Practice & Research. Clinical Rheumatology, 23(4), 539–547. <a href="https://doi.org/10.1016/j.berh.2008.12.007">https://doi.org/10.1016/j.berh.2008.12.007</a></li>
<li>Bonanni, P., Zanella, B., Santomauro, F., Lorini, C., Bechini, A., & Boccalini, S. (2017). Safety and perception: What are the greatest enemies of HPV vaccination programmes? Vaccine. <a href="https://doi.org/10.1016/j.vaccine.2017.05.071 ">https://doi.org/10.1016/j.vaccine.2017.05.071 </a></li>
<li>Bosch, F. X., & Muñoz, N. (2002). The viral etiology of cervical cancer. Virus Research, 89(2), 183–190. <a href="https://doi.org/10.1016/S0168-1702(02)00187-9">https://doi.org/10.1016/S0168-1702(02)00187-9</a></li>
<li>Bruni, L., Diaz, M., Castellsagué, M., Ferrer, E., Bosch, F. X., & de Sanjosé, S. (2010). Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. The Journal of Infectious Diseases, 202(12), 1789–1799.<a href=" https://doi.org/10.1086/657321 "> https://doi.org/10.1086/657321 </a></li>
<li>Calhoun, E. S., McGovern, R. M., Janney, C. A., Cerhan, J. R., Iturria, S. J., Smith, D. I., . . . Persing, D. H. (2002). Host genetic polymorphism analysis in cervical cancer. Clinical Chemistry, 48, 1218–1224.</li>
<li>Cancer, I.A.f.R.o., and Organization, W.H. (2016). GLOBOCAN 2012: Cancer Incidence and Mortality Worldwide.</li>
<li>Cancer, I. C. E. S. C. (2007). Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. Lancet, 370(9599), 1609–1621.<a href=" https://doi.org/10.1016/S0140-6736(07)61684-5 "> https://doi.org/10.1016/S0140-6736(07)61684-5 </a></li>
<li>Castellsagué, X., Bosch, F.X., and Muñoz, N. (2003). The male role in cervical cancer. salud pública de méxico 45, 345-353.</li>
<li>Chidyaonga-Maseko, F., Chirwa, M. L., & Muula, A. S. (2015). Underutilization of cervical cancer prevention services in low and middle income countries: A review of contributing factors. The Pan African Medical Journal, •••, 21.</li>
<li>Cho, H., Kim, M. K., Lee, J. K., Son, S. K., Lee, K.-B., Lee, J.-M., . . . Kim, J.-H. (2009). Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: A case-control study. Clinical Chemistry and Laboratory Medicine, 47(8), 1005–1012. <a href="https://doi.org/10.1515/CCLM.2009.221">https://doi.org/10.1515/CCLM.2009.221</a></li>
<li>Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013). Human papillomavirus and cervical cancer. Lancet, 382(9895), 889–899. <a href="https://doi.org/10.1016/S0140-6736(13)60022-7">https://doi.org/10.1016/S0140-6736(13)60022-7</a></li>
<li>De Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. The Lancet. Infectious Diseases, 7(7), 453–459. <a href="https://doi.org/10.1016/S1473-3099(07)70158-5">https://doi.org/10.1016/S1473-3099(07)70158-5</a></li>
<li>Denny, L. (2012). Cervical cancer: Prevention and treatment. Discovery Medicine, 14, 125–131.</li>
<li>Duclos, P. (2009). Human papillomavirus vaccines: WHO position paper. Biologicals.</li>
<li>Durowade, K., Osagbemi, G., Salaudeen, A., Musa, O., Akande, T., Babatunde, O., . . . Ibrahim, O. (2012). Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria. Journal of Preventive Medicine and Hygiene, •••, 53.</li>
<li>Edelstein, Z. R., Madeleine, M. M., Hughes, J. P., Johnson, L. G., Schwartz, S. M., Galloway, D. A., . . . Koutsky, L. A. (2009). Age of diagnosis of squamous cell cervical carcinoma and early sexual experience. Cancer Epidemiology and Prevention Biomarkers, 18(4), 1070–1076. <a href="https://doi.org/10.1158/1055-9965.EPI-08-0707">https://doi.org/10.1158/1055-9965.EPI-08-0707</a></li>
<li>Ferenczy, A., Coutlée, F., Franco, E., & Hankins, C. (2003). Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: A review of recent developments. Canadian Medical Association Journal, 169, 431–434.</li>
<li>Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., . . . Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, •••, 136.</li>
<li>Ferrante, J. M., Fyffe, D. C., Vega, M. L., Piasecki, A. K., Ohman‐Strickland, P. A., & Crabtree, B. F. (2010). Family physicians’ barriers to cancer screening in extremely obese patients. Obesity (Silver Spring, Md.), 18(6), 1153–1159. <a href="https://doi.org/10.1038/oby.2009.481">https://doi.org/10.1038/oby.2009.481</a></li>
<li>Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., . . . Wolfe, C. (2015). The global burden of cancer 2013. JAMA Oncology, 1(4), 505–527. <a href="https://doi.org/10.1001/jamaoncol.2015.0735">https://doi.org/10.1001/jamaoncol.2015.0735</a></li>
<li>Fonseca-Moutinho, J. A. (2011). Smoking and cervical cancer. ISRN Obstetrics and Gynecology, •••, 2011.</li>
<li>Friedman, A. M., Hemler, J. R., Rossetti, E., Clemow, L. P., & Ferrante, J. M. (2012). Obese women’s barriers to mammography and pap smear: The possible role of personality. Obesity (Silver Spring, Md.), 20(8), 1611–1617. <a href="https://doi.org/10.1038/oby.2012.50">https://doi.org/10.1038/oby.2012.50</a></li>
<li>Galani, E., & Christodoulou, C. (2009). Human papilloma viruses and cancer in the post‐vaccine era. Clinical Microbiology and Infection, 15(11), 977–981. <a href="https://doi.org/10.1111/j.1469-0691.2009.03032.x">https://doi.org/10.1111/j.1469-0691.2009.03032.x</a></li>
<li>Ganesan, S., Subbiah, V.N., and Michael, J.C.J. (2015). Associated factors with cervical pre-malignant lesions among the married fisher women community at Sadras, Tamil Nadu. Asia-Pacific journal of oncology nursing 2, 42.</li>
<li>Ghosh, C., Baker, J. A., Moysich, K. B., Rivera, R., Brasure, J. R., & McCann, S. E. (2008). Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutrition and Cancer, 60(3), 331–341. <a href="https://doi.org/10.1080/01635580701861769">https://doi.org/10.1080/01635580701861769</a></li>
<li>Gonçalves, A. K., Cobucci, R. N., Rodrigues, H. M., Melo, A. G., & Giraldo, P. C. (2014). Safety, tolerability and side effects of human papillomavirus vaccines: A systematic quantitative review. The Brazilian Journal of Infectious Diseases, 18(6), 651–659. <a href="https://doi.org/10.1016/j.bjid.2014.02.005">https://doi.org/10.1016/j.bjid.2014.02.005</a></li>
<li>González, A., Colin, D., Franceschi, S., Goodill, A., Green, J., Peto, J., . . . Skegg, D. (2006). Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. International Journal of Cancer, 118(6), 1481–1495. <a href="https://doi.org/10.1002/ijc.21493">https://doi.org/10.1002/ijc.21493</a></li>
<li>González, C. A., Travier, N., Luján‐Barroso, L., Castellsagué, X., Bosch, F. X., Roura, E., . . . Pala, V. (2011). Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study. International Journal of Cancer, 129(2), 449–459. <a href="https://doi.org/10.1002/ijc.25679">https://doi.org/10.1002/ijc.25679</a></li>
<li>Hernandez, B. Y., McDuffie, K., Wilkens, L. R., Kamemoto, L., & Goodman, M. T. (2003). Diet and premalignant lesions of the cervix: Evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12. Cancer Causes & Control, 14(9), 859–870. <a href="https://doi.org/10.1023/B:CACO.0000003841.54413.98">https://doi.org/10.1023/B:CACO.0000003841.54413.98</a></li>
<li>Herrero, R., González, P., & Markowitz, L. E. (2015). Present status of human papillomavirus vaccine development and implementation. The Lancet. Oncology, 16(5), e206–e216. <a href="https://doi.org/10.1016/S1470-2045(14)70481-4">https://doi.org/10.1016/S1470-2045(14)70481-4</a></li>
<li>Heydari, N., Oskouee, M. A., Vaezi, T., Shoja, Z., Esmaeili, H. A., Hamkar, R., . . . Jalilvand, S. (2017). Type‐specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran. Journal of Medical Virology.</li>
<li>Hildesheim, A., Herrero, R., Castle, P. E., Wacholder, S., Bratti, M., Sherman, M., . . . Rodríguez, A. C. (2001). HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica. British Journal of Cancer, 84(9), 1219–1226. <a href="https://doi.org/10.1054/bjoc.2001.1779">https://doi.org/10.1054/bjoc.2001.1779</a></li>
<li>Hildesheim, A., & Wang, S. S. (2002). Host and viral genetics and risk of cervical cancer: A review. Virus Research, 89(2), 229–240. <a href="https://doi.org/10.1016/S0168-1702(02)00191-0">https://doi.org/10.1016/S0168-1702(02)00191-0</a></li>
<li>Ibfelt, E., Kjaer, S., Høgdall, C., Steding-Jessen, M., Kjaer, T., Osler, M., . . . Dalton, S. O. (2013). 'Socioeconomic position and survival after cervical cancer: Influence of cancer stage, comorbidity and smoking among Danish women diagnosed between 2005 and 2010. British Journal of Cancer, 109(9), 2489–2495. <a href="https://doi.org/10.1038/bjc.2013.558">https://doi.org/10.1038/bjc.2013.558</a></li>
<li>Jensen, K., Schmiedel, S., Norrild, B., Frederiksen, K., Iftner, T., & Kjaer, S. (2013). Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: A 13-year follow-up. British Journal of Cancer, 108(1), 234–239. <a href="https://doi.org/10.1038/bjc.2012.513">https://doi.org/10.1038/bjc.2012.513</a></li>
<li>Kim, J., Kim, B. K., Lee, C. H., Seo, S. S., Park, S.-Y., & Roh, J.-W. (2012). Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women. International Journal of Gynecological Cancer, 22, 1570–1576.</li>
<li>Kim, J.-Y., & Kang, H.-T. (2016). Association between Socioeconomic Status and Cancer Screening in Koreans over 40 Years in Age Based on the 2010–2012 Korean National Health and Nutrition Examination Survey. Korean Journal of Family Medicine, 37(5), 287–292. <a href="https://doi.org/10.4082/kjfm.2016.37.5.287">https://doi.org/10.4082/kjfm.2016.37.5.287</a></li>
<li>Kim, S.C., Glynn, R.J., Giovannucci, E., Hernández-Díaz, S., Liu, J., Feldman, S., Karlson, E.W., Schneeweiss, S., and Solomon, D.H. (2014). Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Annals of the rheumatic diseases, annrheumdis-2013-204993.</li>
<li>Kiss, E., Kovacs, L., & Szodoray, P. (2010). Malignancies in systemic lupus erythematosus. Autoimmunity Reviews, 9(4), 195–199. <a href="https://doi.org/10.1016/j.autrev.2009.07.004">https://doi.org/10.1016/j.autrev.2009.07.004</a></li>
<li>Koskela, P., Anttila, T., Bjørge, T., Brunsvig, A., Dillner, J., Hakama, M., . . . Lenner, P. (2000). Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. International Journal of Cancer, 85(1), 35–39. <a href="https://doi.org/10.1002/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A">https://doi.org/10.1002/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A</a></li>
<li>La Vecchia, C., & Boccia, S. (2014). Oral contraceptives, human papillomavirus and cervical cancer. European Journal of Cancer Prevention, 23(2), 110–112. <a href="https://doi.org/10.1097/CEJ.0000000000000000">https://doi.org/10.1097/CEJ.0000000000000000</a></li>
<li>Labani, L., Andallu, B., Meera, M., Asthana, S., & Satyanarayana, L. (2009). Food consumption pattern in cervical carcinoma patients and controls. Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology, 30(2), 71. <a href="https://doi.org/10.4103/0971-5851.60051">https://doi.org/10.4103/0971-5851.60051</a></li>
<li>Lacey, J. V., Swanson, C. A., Brinton, L. A., Altekruse, S. F., Barnes, W. A., Gravitt, P. E., . . . Mortel, R. (2003). Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer, 98(4), 814–821. <a href="https://doi.org/10.1002/cncr.11567">https://doi.org/10.1002/cncr.11567</a></li>
<li>Lee, J. K., So, K. A., Piyathilake, C. J., & Kim, M. K. (2013). Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS One, 8(6), e66555. <a href="https://doi.org/10.1371/journal.pone.0066555">https://doi.org/10.1371/journal.pone.0066555</a></li>
<li>Lehtinen, M., Koskela, P., Jellum, E., Bloigu, A., Anttila, T., Hallmans, G., . . . Dillner, J. (2002). Herpes simplex virus and risk of cervical cancer: A longitudinal, nested case-control study in the nordic countries. American Journal of Epidemiology, 156(8), 687–692. <a href="https://doi.org/10.1093/aje/kwf098">https://doi.org/10.1093/aje/kwf098</a></li>
<li>Leinonen, M. K., Campbell, S., Klungsøyr, O., Lönnberg, S., Hansen, B. T., & Nygård, M. (2017). Personal and provider level factors influence participation to cervical cancer screening: A retrospective register-based study of 1.3 million women in Norway. Preventive Medicine, 94, 31–39. <a href="https://doi.org/10.1016/j.ypmed.2016.11.018">https://doi.org/10.1016/j.ypmed.2016.11.018</a></li>
<li>Leyden, W. A., Manos, M. M., Geiger, A. M., Weinmann, S., Mouchawar, J., Bischoff, K., . . . Taplin, S. H. (2005). Cervical cancer in women with comprehensive health care access: Attributable factors in the screening process. Journal of the National Cancer Institute, 97(9), 675–683. <a href="https://doi.org/10.1093/jnci/dji115">https://doi.org/10.1093/jnci/dji115</a></li>
<li>Liu, H., Ding, Q., Yang, K., Zhang, T., Li, G., & Wu, G. (2010). Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia. Rheumatology, 50(2), 343–348. <a href="https://doi.org/10.1093/rheumatology/keq304">https://doi.org/10.1093/rheumatology/keq304</a></li>
<li>Liu, Z.-C., Liu, W.-D., Liu, Y.-H., Ye, X.-H., & Chen, S.-D. (2015). Multiple sexual partners as a potential independent risk factor for cervical cancer: A meta-analysis of epidemiological studies. Asian Pacific Journal of Cancer Prevention, 16(9), 3893–3900. <a href="https://doi.org/10.7314/APJCP.2015.16.9.3893">https://doi.org/10.7314/APJCP.2015.16.9.3893</a></li>
<li>Louie, K., De Sanjose, S., Diaz, M., Castellsague, X., Herrero, R., Meijer, C., . . . Bosch, F. (2009). Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. British Journal of Cancer, 100(7), 1191–1197. <a href="https://doi.org/10.1038/sj.bjc.6604974">https://doi.org/10.1038/sj.bjc.6604974</a></li>
<li>Ludman, E. J., Ichikawa, L. E., Simon, G. E., Rohde, P., Arterburn, D., Operskalski, B. H., . . . Jeffery, R. W. (2010). Breast and cervical cancer screening: Specific effects of depression and obesity. American Journal of Preventive Medicine, 38(3), 303–310. <a href="https://doi.org/10.1016/j.amepre.2009.10.039">https://doi.org/10.1016/j.amepre.2009.10.039</a></li>
<li>Ma, Y., Collins, S., Young, L. S., Murray, P. G., & Woodman, C. B. (2011). Smoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: A longitudinal study. British Journal of Cancer, 104(9), 1500–1504. <a href="https://doi.org/10.1038/bjc.2011.113">https://doi.org/10.1038/bjc.2011.113</a></li>
<li>Makuza, J. D., Nsanzimana, S., Muhimpundu, M. A., Pace, L. E., Ntaganira, J., & Riedel, D. J. (2015). Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. The Pan African Medical Journal, •••, 22.</li>
<li>Maruthur, N. M., Bolen, S. D., Brancati, F. L., & Clark, J. M. (2009). The association of obesity and cervical cancer screening: A systematic review and meta‐analysis. Obesity (Silver Spring, Md.), 17(2), 375–381. <a href="https://doi.org/10.1038/oby.2008.480">https://doi.org/10.1038/oby.2008.480</a></li>
<li>Mbulawa, Z. Z., Marais, D. J., Johnson, L. F., Boulle, A., Coetzee, D., & Williamson, A.-L. (2010). Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. The Journal of General Virology, 91(12), 3023–3031. <a href="https://doi.org/10.1099/vir.0.020669-0">https://doi.org/10.1099/vir.0.020669-0</a></li>
<li>Momenimovahed, Z., Ghoncheh, M., Pakzad, R., Hasanpour, H., & Salehiniya, H. (2017). Incidence and mortality of uterine cancer and relationship with Human Development Index in the world. CUKUROVA MEDICAL JOURNAL, 42, 233–240. <a href="https://doi.org/10.17826/cutf.322865">https://doi.org/10.17826/cutf.322865</a></li>
<li>Monie, A., Hung, C.-F., Roden, R., & Wu, T. C. (2008). Cervarix™: A vaccine for the prevention of HPV 16, 18-associated cervical cancer. Biologics, 2, 107.</li>
<li>Monnat, S. M. (2014). Race/ethnicity and the socioeconomic status gradient in women’s cancer screening utilization: A case of diminishing returns? Journal of Health Care for the Poor and Underserved, 25(1), 332–356. <a href="https://doi.org/10.1353/hpu.2014.0050">https://doi.org/10.1353/hpu.2014.0050</a></li>
<li>Moreno, V., Bosch, F. X., Muñoz, N., Meijer, C. J., Shah, K. V., Walboomers, J. M., . . . Franceschi, S. (2002). Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet, 359(9312), 1085–1092. <a href="https://doi.org/10.1016/S0140-6736(02)08150-3">https://doi.org/10.1016/S0140-6736(02)08150-3</a></li>
<li>Muñoz, N., Franceschi, S., Bosetti, C., Moreno, V., Herrero, R., Smith, J. S., . . . Bosch, F. X. (2002). Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet, 359(9312), 1093–1101. <a href="https://doi.org/10.1016/S0140-6736(02)08151-5">https://doi.org/10.1016/S0140-6736(02)08151-5</a></li>
<li>Munoz, N., Hernandez-Suarez, G., Mendez, F., Molano, M., Posso, H., Moreno, V., . . . Munoz, A. (2009). Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. British Journal of Cancer, 100(7), 1184–1190. <a href="https://doi.org/10.1038/sj.bjc.6604972">https://doi.org/10.1038/sj.bjc.6604972</a></li>
<li>Ogunbowale, T., & Lawoyin, T. O. (2008). Cervical cancer risk factors and predictors of cervical dysplasia among women in south‐west Nigeria. The Australian Journal of Rural Health, 16(6), 338–342. <a href="https://doi.org/10.1111/j.1440-1584.2008.01013.x">https://doi.org/10.1111/j.1440-1584.2008.01013.x</a></li>
<li>Palefsky, J. (2007). Human papillomavirus infection in HIV-infected persons. Topics in HIV medicine: a publication of the International AIDS Society, USA 15, 130-133.<br>Pantanowitz, L., & Michelow, P. (2011). Review of human immunodeficiency virus (HIV) and squamous lesions of the uterine cervix. Diagnostic Cytopathology, 39(1), 65–72. <a href="https://doi.org/10.1002/dc.21364">https://doi.org/10.1002/dc.21364</a></li>
<li>Patel, S., & Chiplunkar, S. (2009). Host immune responses to cervical cancer. Current Opinion in Obstetrics & Gynecology, 21(1), 54–59. <a href="https://doi.org/10.1097/GCO.0b013e32831a9890">https://doi.org/10.1097/GCO.0b013e32831a9890</a></li>
<li>Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016). Global burden of cancers attributable to infections in 2012: A synthetic analysis. The Lancet. Global Health, 4(9), e609–e616. <a href="https://doi.org/10.1016/S2214-109X(16)30143-7">https://doi.org/10.1016/S2214-109X(16)30143-7</a></li>
<li>Plummer, M., Herrero, R., Franceschi, S., Meijer, C. J., Snijders, P., Bosch, F. X., . . . Muñoz, N. (2003). Smoking and cervical cancer: Pooled analysis of the IARC multi-centric case–control study. Cancer Causes & Control, 14(9), 805–814. <a href="https://doi.org/10.1023/B:CACO.0000003811.98261.3e">https://doi.org/10.1023/B:CACO.0000003811.98261.3e</a></li>
<li>Poorolajal, J., & Jenabi, E. (2016). The association between BMI and cervical cancer risk: A meta-analysis. European Journal of Cancer Prevention, 25(3), 232–238. <a href="https://doi.org/10.1097/CEJ.0000000000000164">https://doi.org/10.1097/CEJ.0000000000000164</a></li>
<li>Rader, J. S. (2009). Host and viral genetics and risk of cervical cancer. In The Role of Genetics in Breast and Reproductive Cancers (pp. 263–284). Springer. <a href="https://doi.org/10.1007/978-1-4419-0477-5_12">https://doi.org/10.1007/978-1-4419-0477-5_12</a></li>
<li>Rossi, P. G., Baldacchini, F., & Ronco, G. (2014). The possible effects on socio-economic inequalities of introducing HPV testing as primary test in cervical cancer screening programs. Frontiers in Oncology, •••, 4.</li>
<li>Roura, E., Castellsagué, X., Pawlita, M., Travier, N., Waterboer, T., Margall, N., . . . Gram, I. T. (2014). Smoking as a major risk factor for cervical cancer and pre‐cancer: Results from the EPIC cohort. International Journal of Cancer, 135(2), 453–466. <a href="https://doi.org/10.1002/ijc.28666">https://doi.org/10.1002/ijc.28666</a></li>
<li>Siddiqui, M. A. A., & Perry, C. M. (2006). Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil®). Drugs, 66(9), 1263–1271. <a href="https://doi.org/10.2165/00003495-200666090-00008">https://doi.org/10.2165/00003495-200666090-00008</a></li>
<li>Siegel, E. M., Salemi, J. L., Villa, L. L., Ferenczy, A., Franco, E. L., & Giuliano, A. R. (2010). Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecologic Oncology, 118(3), 289–294. <a href="https://doi.org/10.1016/j.ygyno.2010.05.022">https://doi.org/10.1016/j.ygyno.2010.05.022</a></li>
<li>Silva, J., Cerqueira, F., & Medeiros, R. (2014). Chlamydia trachomatis infection: Implications for HPV status and cervical cancer. Archives of Gynecology and Obstetrics, 289(4), 715–723. <a href="https://doi.org/10.1007/s00404-013-3122-3">https://doi.org/10.1007/s00404-013-3122-3</a></li>
<li>Simon, T. A., Thompson, A., Gandhi, K. K., Hochberg, M. C., & Suissa, S. (2015). Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis. Arthritis Research & Therapy, 17(1), 212. <a href="https://doi.org/10.1186/s13075-015-0728-9">https://doi.org/10.1186/s13075-015-0728-9</a></li>
<li>Smith, J. S., Bosetti, C., Muñoz, N., Herrero, R., Bosch, F. X., Eluf-Neto, J., . . . Peeling, R. W. (2004). Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study. International Journal of Cancer, 111(3), 431–439. <a href="https://doi.org/10.1002/ijc.20257">https://doi.org/10.1002/ijc.20257</a></li>
<li>Smith, J. S., Herrero, R., Bosetti, C., Munoz, N., Bosch, F. X., Eluf-Neto, J., . . . Franceschi, S. (2002). Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. Journal of the National Cancer Institute, 94(21), 1604–1613. <a href="https://doi.org/10.1093/jnci/94.21.1604">https://doi.org/10.1093/jnci/94.21.1604</a></li>
<li>Tomita, L. Y., Costa, M. C., Andreoli, M. A. A., Villa, L. L., Franco, E. L., & Cardoso, M. A. (2010). Diet and serum micronutrients in relation to cervical neoplasia and cancer among low‐income Brazilian women. International Journal of Cancer, 126(3), 703–714. <a href="https://doi.org/10.1002/ijc.24793">https://doi.org/10.1002/ijc.24793</a></li>
<li>Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017). Global cancer in women: burden and trends. AACR.</li>
<li>Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016). Global cancer incidence and mortality rates and trends—An update. Cancer Epidemiology and Prevention Biomarkers, 25(1), 16–27. <a href="https://doi.org/10.1158/1055-9965.EPI-15-0578">https://doi.org/10.1158/1055-9965.EPI-15-0578</a></li>
<li>Ueda, K., Kawachi, I., & Tsukuma, H. (2006). Cervical and corpus cancer survival disparities by socioeconomic status in a metropolitan area of Japan. Cancer Science, 97(4), 283–291. <a href="https://doi.org/10.1111/j.1349-7006.2006.00179.x">https://doi.org/10.1111/j.1349-7006.2006.00179.x</a></li>
<li>Vaccarella, S., Laversanne, M., Ferlay, J., & Bray, F. (2017). Cervical cancer in Africa, Latin America and the Caribbean, and Asia: Regional inequalities and changing trends. International Journal of Cancer, 141(10), 1997–2001. <a href="https://doi.org/10.1002/ijc.30901">https://doi.org/10.1002/ijc.30901</a></li>
<li>Vaccarella, S., Lortet-Tieulent, J., Plummer, M., Franceschi, S., & Bray, F. (2013). Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors. European Journal of Cancer, 49(15), 3262–3273. <a href="https://doi.org/10.1016/j.ejca.2013.04.024">https://doi.org/10.1016/j.ejca.2013.04.024</a></li>
<li>Vanakankovit, N., and Taneepanichskul, S. (2008). Effect of oral contraceptives on risk of cervical cancer. Medical journal of the Medical Association of Thailand 91, 7.</li>
<li>Wang, S. S., Gonzalez, P., Yu, K., Porras, C., Li, Q., Safaeian, M., . . . Schiffman, M. (2010). Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One, 5(1), e8667. <a href="https://doi.org/10.1371/journal.pone.0008667">https://doi.org/10.1371/journal.pone.0008667</a></li>
<li>Wardak, S. (2016). Human Papillomavirus (HPV) and cervical cancer. Medycyna Doswiadczalna i Mikrobiologia, 68, 73.</li>
<li>Wee, C. C., McCarthy, E. P., Davis, R. B., & Phillips, R. S. (2000). Screening for cervical and breast cancer: Is obesity an unrecognized barrier to preventive care? Annals of Internal Medicine, 132(9), 697–704. <a href="https://doi.org/10.7326/0003-4819-132-9-200005020-00003">https://doi.org/10.7326/0003-4819-132-9-200005020-00003</a></li>
<li>Wigle, J., Coast, E., & Watson-Jones, D. (2013). Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine, 31(37), 3811–3817. <a href="https://doi.org/10.1016/j.vaccine.2013.06.016">https://doi.org/10.1016/j.vaccine.2013.06.016</a></li>
<li>Zur Hausen, H. (2002). Papillomaviruses and cancer: From basic studies to clinical application. Nature Reviews. Cancer, 2(5), 342–350. <a href="https://doi.org/10.1038/nrc798">https://doi.org/10.1038/nrc798</a></li>
</ol>
<li>Akinyemiju, T., Ogunsina, K., Sakhuja, S., Ogbhodo, V., & Braithwaite, D. (2016). Life-course socioeconomic status and breast and cervical cancer screening: Analysis of the WHO9s Study on Global Ageing and Adult Health (SAGE). BMJ Open, 6(11), e012753. <a href="https://doi.org/10.1136/bmjopen-2016-012753">https://doi.org/10.1136/bmjopen-2016-012753 </a></li>
<li>Al-Sherbeni, H. H., Fahmy, A. M., & Sherif, N. (2015). Predisposition to cervical atypia in systemic lupus erythematosus: A clinical and cytopathological study. Autoimmune Diseases, •••, 2015.</li>
<li>Benard, V. B., Johnson, C. J., Thompson, T. D., Roland, K. B., Lai, S. M., Cokkinides, V., . . . Weir, H. K. (2008). Examining the association between socioeconomic status and potential human papillomavirus‐associated cancers. Cancer, 113(S10), 2910–2918.<a href=" https://doi.org/10.1002/cncr.23742"> https://doi.org/10.1002/cncr.23742</a></li>
<li>Bernatsky, S., Ramsey-Goldman, R., & Clarke, A. E. (2009). Malignancy in systemic lupus erythematosus: What have we learned? Best Practice & Research. Clinical Rheumatology, 23(4), 539–547. <a href="https://doi.org/10.1016/j.berh.2008.12.007">https://doi.org/10.1016/j.berh.2008.12.007</a></li>
<li>Bonanni, P., Zanella, B., Santomauro, F., Lorini, C., Bechini, A., & Boccalini, S. (2017). Safety and perception: What are the greatest enemies of HPV vaccination programmes? Vaccine. <a href="https://doi.org/10.1016/j.vaccine.2017.05.071 ">https://doi.org/10.1016/j.vaccine.2017.05.071 </a></li>
<li>Bosch, F. X., & Muñoz, N. (2002). The viral etiology of cervical cancer. Virus Research, 89(2), 183–190. <a href="https://doi.org/10.1016/S0168-1702(02)00187-9">https://doi.org/10.1016/S0168-1702(02)00187-9</a></li>
<li>Bruni, L., Diaz, M., Castellsagué, M., Ferrer, E., Bosch, F. X., & de Sanjosé, S. (2010). Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. The Journal of Infectious Diseases, 202(12), 1789–1799.<a href=" https://doi.org/10.1086/657321 "> https://doi.org/10.1086/657321 </a></li>
<li>Calhoun, E. S., McGovern, R. M., Janney, C. A., Cerhan, J. R., Iturria, S. J., Smith, D. I., . . . Persing, D. H. (2002). Host genetic polymorphism analysis in cervical cancer. Clinical Chemistry, 48, 1218–1224.</li>
<li>Cancer, I.A.f.R.o., and Organization, W.H. (2016). GLOBOCAN 2012: Cancer Incidence and Mortality Worldwide.</li>
<li>Cancer, I. C. E. S. C. (2007). Cervical cancer and hormonal contraceptives: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. Lancet, 370(9599), 1609–1621.<a href=" https://doi.org/10.1016/S0140-6736(07)61684-5 "> https://doi.org/10.1016/S0140-6736(07)61684-5 </a></li>
<li>Castellsagué, X., Bosch, F.X., and Muñoz, N. (2003). The male role in cervical cancer. salud pública de méxico 45, 345-353.</li>
<li>Chidyaonga-Maseko, F., Chirwa, M. L., & Muula, A. S. (2015). Underutilization of cervical cancer prevention services in low and middle income countries: A review of contributing factors. The Pan African Medical Journal, •••, 21.</li>
<li>Cho, H., Kim, M. K., Lee, J. K., Son, S. K., Lee, K.-B., Lee, J.-M., . . . Kim, J.-H. (2009). Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: A case-control study. Clinical Chemistry and Laboratory Medicine, 47(8), 1005–1012. <a href="https://doi.org/10.1515/CCLM.2009.221">https://doi.org/10.1515/CCLM.2009.221</a></li>
<li>Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013). Human papillomavirus and cervical cancer. Lancet, 382(9895), 889–899. <a href="https://doi.org/10.1016/S0140-6736(13)60022-7">https://doi.org/10.1016/S0140-6736(13)60022-7</a></li>
<li>De Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. The Lancet. Infectious Diseases, 7(7), 453–459. <a href="https://doi.org/10.1016/S1473-3099(07)70158-5">https://doi.org/10.1016/S1473-3099(07)70158-5</a></li>
<li>Denny, L. (2012). Cervical cancer: Prevention and treatment. Discovery Medicine, 14, 125–131.</li>
<li>Duclos, P. (2009). Human papillomavirus vaccines: WHO position paper. Biologicals.</li>
<li>Durowade, K., Osagbemi, G., Salaudeen, A., Musa, O., Akande, T., Babatunde, O., . . . Ibrahim, O. (2012). Prevalence and risk factors of cervical cancer among women in an urban community of Kwara State, north central Nigeria. Journal of Preventive Medicine and Hygiene, •••, 53.</li>
<li>Edelstein, Z. R., Madeleine, M. M., Hughes, J. P., Johnson, L. G., Schwartz, S. M., Galloway, D. A., . . . Koutsky, L. A. (2009). Age of diagnosis of squamous cell cervical carcinoma and early sexual experience. Cancer Epidemiology and Prevention Biomarkers, 18(4), 1070–1076. <a href="https://doi.org/10.1158/1055-9965.EPI-08-0707">https://doi.org/10.1158/1055-9965.EPI-08-0707</a></li>
<li>Ferenczy, A., Coutlée, F., Franco, E., & Hankins, C. (2003). Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: A review of recent developments. Canadian Medical Association Journal, 169, 431–434.</li>
<li>Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., . . . Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, •••, 136.</li>
<li>Ferrante, J. M., Fyffe, D. C., Vega, M. L., Piasecki, A. K., Ohman‐Strickland, P. A., & Crabtree, B. F. (2010). Family physicians’ barriers to cancer screening in extremely obese patients. Obesity (Silver Spring, Md.), 18(6), 1153–1159. <a href="https://doi.org/10.1038/oby.2009.481">https://doi.org/10.1038/oby.2009.481</a></li>
<li>Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., . . . Wolfe, C. (2015). The global burden of cancer 2013. JAMA Oncology, 1(4), 505–527. <a href="https://doi.org/10.1001/jamaoncol.2015.0735">https://doi.org/10.1001/jamaoncol.2015.0735</a></li>
<li>Fonseca-Moutinho, J. A. (2011). Smoking and cervical cancer. ISRN Obstetrics and Gynecology, •••, 2011.</li>
<li>Friedman, A. M., Hemler, J. R., Rossetti, E., Clemow, L. P., & Ferrante, J. M. (2012). Obese women’s barriers to mammography and pap smear: The possible role of personality. Obesity (Silver Spring, Md.), 20(8), 1611–1617. <a href="https://doi.org/10.1038/oby.2012.50">https://doi.org/10.1038/oby.2012.50</a></li>
<li>Galani, E., & Christodoulou, C. (2009). Human papilloma viruses and cancer in the post‐vaccine era. Clinical Microbiology and Infection, 15(11), 977–981. <a href="https://doi.org/10.1111/j.1469-0691.2009.03032.x">https://doi.org/10.1111/j.1469-0691.2009.03032.x</a></li>
<li>Ganesan, S., Subbiah, V.N., and Michael, J.C.J. (2015). Associated factors with cervical pre-malignant lesions among the married fisher women community at Sadras, Tamil Nadu. Asia-Pacific journal of oncology nursing 2, 42.</li>
<li>Ghosh, C., Baker, J. A., Moysich, K. B., Rivera, R., Brasure, J. R., & McCann, S. E. (2008). Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutrition and Cancer, 60(3), 331–341. <a href="https://doi.org/10.1080/01635580701861769">https://doi.org/10.1080/01635580701861769</a></li>
<li>Gonçalves, A. K., Cobucci, R. N., Rodrigues, H. M., Melo, A. G., & Giraldo, P. C. (2014). Safety, tolerability and side effects of human papillomavirus vaccines: A systematic quantitative review. The Brazilian Journal of Infectious Diseases, 18(6), 651–659. <a href="https://doi.org/10.1016/j.bjid.2014.02.005">https://doi.org/10.1016/j.bjid.2014.02.005</a></li>
<li>González, A., Colin, D., Franceschi, S., Goodill, A., Green, J., Peto, J., . . . Skegg, D. (2006). Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. International Journal of Cancer, 118(6), 1481–1495. <a href="https://doi.org/10.1002/ijc.21493">https://doi.org/10.1002/ijc.21493</a></li>
<li>González, C. A., Travier, N., Luján‐Barroso, L., Castellsagué, X., Bosch, F. X., Roura, E., . . . Pala, V. (2011). Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study. International Journal of Cancer, 129(2), 449–459. <a href="https://doi.org/10.1002/ijc.25679">https://doi.org/10.1002/ijc.25679</a></li>
<li>Hernandez, B. Y., McDuffie, K., Wilkens, L. R., Kamemoto, L., & Goodman, M. T. (2003). Diet and premalignant lesions of the cervix: Evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12. Cancer Causes & Control, 14(9), 859–870. <a href="https://doi.org/10.1023/B:CACO.0000003841.54413.98">https://doi.org/10.1023/B:CACO.0000003841.54413.98</a></li>
<li>Herrero, R., González, P., & Markowitz, L. E. (2015). Present status of human papillomavirus vaccine development and implementation. The Lancet. Oncology, 16(5), e206–e216. <a href="https://doi.org/10.1016/S1470-2045(14)70481-4">https://doi.org/10.1016/S1470-2045(14)70481-4</a></li>
<li>Heydari, N., Oskouee, M. A., Vaezi, T., Shoja, Z., Esmaeili, H. A., Hamkar, R., . . . Jalilvand, S. (2017). Type‐specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran. Journal of Medical Virology.</li>
<li>Hildesheim, A., Herrero, R., Castle, P. E., Wacholder, S., Bratti, M., Sherman, M., . . . Rodríguez, A. C. (2001). HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica. British Journal of Cancer, 84(9), 1219–1226. <a href="https://doi.org/10.1054/bjoc.2001.1779">https://doi.org/10.1054/bjoc.2001.1779</a></li>
<li>Hildesheim, A., & Wang, S. S. (2002). Host and viral genetics and risk of cervical cancer: A review. Virus Research, 89(2), 229–240. <a href="https://doi.org/10.1016/S0168-1702(02)00191-0">https://doi.org/10.1016/S0168-1702(02)00191-0</a></li>
<li>Ibfelt, E., Kjaer, S., Høgdall, C., Steding-Jessen, M., Kjaer, T., Osler, M., . . . Dalton, S. O. (2013). 'Socioeconomic position and survival after cervical cancer: Influence of cancer stage, comorbidity and smoking among Danish women diagnosed between 2005 and 2010. British Journal of Cancer, 109(9), 2489–2495. <a href="https://doi.org/10.1038/bjc.2013.558">https://doi.org/10.1038/bjc.2013.558</a></li>
<li>Jensen, K., Schmiedel, S., Norrild, B., Frederiksen, K., Iftner, T., & Kjaer, S. (2013). Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: A 13-year follow-up. British Journal of Cancer, 108(1), 234–239. <a href="https://doi.org/10.1038/bjc.2012.513">https://doi.org/10.1038/bjc.2012.513</a></li>
<li>Kim, J., Kim, B. K., Lee, C. H., Seo, S. S., Park, S.-Y., & Roh, J.-W. (2012). Human papillomavirus genotypes and cofactors causing cervical intraepithelial neoplasia and cervical cancer in Korean women. International Journal of Gynecological Cancer, 22, 1570–1576.</li>
<li>Kim, J.-Y., & Kang, H.-T. (2016). Association between Socioeconomic Status and Cancer Screening in Koreans over 40 Years in Age Based on the 2010–2012 Korean National Health and Nutrition Examination Survey. Korean Journal of Family Medicine, 37(5), 287–292. <a href="https://doi.org/10.4082/kjfm.2016.37.5.287">https://doi.org/10.4082/kjfm.2016.37.5.287</a></li>
<li>Kim, S.C., Glynn, R.J., Giovannucci, E., Hernández-Díaz, S., Liu, J., Feldman, S., Karlson, E.W., Schneeweiss, S., and Solomon, D.H. (2014). Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Annals of the rheumatic diseases, annrheumdis-2013-204993.</li>
<li>Kiss, E., Kovacs, L., & Szodoray, P. (2010). Malignancies in systemic lupus erythematosus. Autoimmunity Reviews, 9(4), 195–199. <a href="https://doi.org/10.1016/j.autrev.2009.07.004">https://doi.org/10.1016/j.autrev.2009.07.004</a></li>
<li>Koskela, P., Anttila, T., Bjørge, T., Brunsvig, A., Dillner, J., Hakama, M., . . . Lenner, P. (2000). Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. International Journal of Cancer, 85(1), 35–39. <a href="https://doi.org/10.1002/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A">https://doi.org/10.1002/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A</a></li>
<li>La Vecchia, C., & Boccia, S. (2014). Oral contraceptives, human papillomavirus and cervical cancer. European Journal of Cancer Prevention, 23(2), 110–112. <a href="https://doi.org/10.1097/CEJ.0000000000000000">https://doi.org/10.1097/CEJ.0000000000000000</a></li>
<li>Labani, L., Andallu, B., Meera, M., Asthana, S., & Satyanarayana, L. (2009). Food consumption pattern in cervical carcinoma patients and controls. Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology, 30(2), 71. <a href="https://doi.org/10.4103/0971-5851.60051">https://doi.org/10.4103/0971-5851.60051</a></li>
<li>Lacey, J. V., Swanson, C. A., Brinton, L. A., Altekruse, S. F., Barnes, W. A., Gravitt, P. E., . . . Mortel, R. (2003). Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer, 98(4), 814–821. <a href="https://doi.org/10.1002/cncr.11567">https://doi.org/10.1002/cncr.11567</a></li>
<li>Lee, J. K., So, K. A., Piyathilake, C. J., & Kim, M. K. (2013). Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS One, 8(6), e66555. <a href="https://doi.org/10.1371/journal.pone.0066555">https://doi.org/10.1371/journal.pone.0066555</a></li>
<li>Lehtinen, M., Koskela, P., Jellum, E., Bloigu, A., Anttila, T., Hallmans, G., . . . Dillner, J. (2002). Herpes simplex virus and risk of cervical cancer: A longitudinal, nested case-control study in the nordic countries. American Journal of Epidemiology, 156(8), 687–692. <a href="https://doi.org/10.1093/aje/kwf098">https://doi.org/10.1093/aje/kwf098</a></li>
<li>Leinonen, M. K., Campbell, S., Klungsøyr, O., Lönnberg, S., Hansen, B. T., & Nygård, M. (2017). Personal and provider level factors influence participation to cervical cancer screening: A retrospective register-based study of 1.3 million women in Norway. Preventive Medicine, 94, 31–39. <a href="https://doi.org/10.1016/j.ypmed.2016.11.018">https://doi.org/10.1016/j.ypmed.2016.11.018</a></li>
<li>Leyden, W. A., Manos, M. M., Geiger, A. M., Weinmann, S., Mouchawar, J., Bischoff, K., . . . Taplin, S. H. (2005). Cervical cancer in women with comprehensive health care access: Attributable factors in the screening process. Journal of the National Cancer Institute, 97(9), 675–683. <a href="https://doi.org/10.1093/jnci/dji115">https://doi.org/10.1093/jnci/dji115</a></li>
<li>Liu, H., Ding, Q., Yang, K., Zhang, T., Li, G., & Wu, G. (2010). Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia. Rheumatology, 50(2), 343–348. <a href="https://doi.org/10.1093/rheumatology/keq304">https://doi.org/10.1093/rheumatology/keq304</a></li>
<li>Liu, Z.-C., Liu, W.-D., Liu, Y.-H., Ye, X.-H., & Chen, S.-D. (2015). Multiple sexual partners as a potential independent risk factor for cervical cancer: A meta-analysis of epidemiological studies. Asian Pacific Journal of Cancer Prevention, 16(9), 3893–3900. <a href="https://doi.org/10.7314/APJCP.2015.16.9.3893">https://doi.org/10.7314/APJCP.2015.16.9.3893</a></li>
<li>Louie, K., De Sanjose, S., Diaz, M., Castellsague, X., Herrero, R., Meijer, C., . . . Bosch, F. (2009). Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. British Journal of Cancer, 100(7), 1191–1197. <a href="https://doi.org/10.1038/sj.bjc.6604974">https://doi.org/10.1038/sj.bjc.6604974</a></li>
<li>Ludman, E. J., Ichikawa, L. E., Simon, G. E., Rohde, P., Arterburn, D., Operskalski, B. H., . . . Jeffery, R. W. (2010). Breast and cervical cancer screening: Specific effects of depression and obesity. American Journal of Preventive Medicine, 38(3), 303–310. <a href="https://doi.org/10.1016/j.amepre.2009.10.039">https://doi.org/10.1016/j.amepre.2009.10.039</a></li>
<li>Ma, Y., Collins, S., Young, L. S., Murray, P. G., & Woodman, C. B. (2011). Smoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: A longitudinal study. British Journal of Cancer, 104(9), 1500–1504. <a href="https://doi.org/10.1038/bjc.2011.113">https://doi.org/10.1038/bjc.2011.113</a></li>
<li>Makuza, J. D., Nsanzimana, S., Muhimpundu, M. A., Pace, L. E., Ntaganira, J., & Riedel, D. J. (2015). Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda. The Pan African Medical Journal, •••, 22.</li>
<li>Maruthur, N. M., Bolen, S. D., Brancati, F. L., & Clark, J. M. (2009). The association of obesity and cervical cancer screening: A systematic review and meta‐analysis. Obesity (Silver Spring, Md.), 17(2), 375–381. <a href="https://doi.org/10.1038/oby.2008.480">https://doi.org/10.1038/oby.2008.480</a></li>
<li>Mbulawa, Z. Z., Marais, D. J., Johnson, L. F., Boulle, A., Coetzee, D., & Williamson, A.-L. (2010). Influence of human immunodeficiency virus and CD4 count on the prevalence of human papillomavirus in heterosexual couples. The Journal of General Virology, 91(12), 3023–3031. <a href="https://doi.org/10.1099/vir.0.020669-0">https://doi.org/10.1099/vir.0.020669-0</a></li>
<li>Momenimovahed, Z., Ghoncheh, M., Pakzad, R., Hasanpour, H., & Salehiniya, H. (2017). Incidence and mortality of uterine cancer and relationship with Human Development Index in the world. CUKUROVA MEDICAL JOURNAL, 42, 233–240. <a href="https://doi.org/10.17826/cutf.322865">https://doi.org/10.17826/cutf.322865</a></li>
<li>Monie, A., Hung, C.-F., Roden, R., & Wu, T. C. (2008). Cervarix™: A vaccine for the prevention of HPV 16, 18-associated cervical cancer. Biologics, 2, 107.</li>
<li>Monnat, S. M. (2014). Race/ethnicity and the socioeconomic status gradient in women’s cancer screening utilization: A case of diminishing returns? Journal of Health Care for the Poor and Underserved, 25(1), 332–356. <a href="https://doi.org/10.1353/hpu.2014.0050">https://doi.org/10.1353/hpu.2014.0050</a></li>
<li>Moreno, V., Bosch, F. X., Muñoz, N., Meijer, C. J., Shah, K. V., Walboomers, J. M., . . . Franceschi, S. (2002). Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet, 359(9312), 1085–1092. <a href="https://doi.org/10.1016/S0140-6736(02)08150-3">https://doi.org/10.1016/S0140-6736(02)08150-3</a></li>
<li>Muñoz, N., Franceschi, S., Bosetti, C., Moreno, V., Herrero, R., Smith, J. S., . . . Bosch, F. X. (2002). Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet, 359(9312), 1093–1101. <a href="https://doi.org/10.1016/S0140-6736(02)08151-5">https://doi.org/10.1016/S0140-6736(02)08151-5</a></li>
<li>Munoz, N., Hernandez-Suarez, G., Mendez, F., Molano, M., Posso, H., Moreno, V., . . . Munoz, A. (2009). Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian women. British Journal of Cancer, 100(7), 1184–1190. <a href="https://doi.org/10.1038/sj.bjc.6604972">https://doi.org/10.1038/sj.bjc.6604972</a></li>
<li>Ogunbowale, T., & Lawoyin, T. O. (2008). Cervical cancer risk factors and predictors of cervical dysplasia among women in south‐west Nigeria. The Australian Journal of Rural Health, 16(6), 338–342. <a href="https://doi.org/10.1111/j.1440-1584.2008.01013.x">https://doi.org/10.1111/j.1440-1584.2008.01013.x</a></li>
<li>Palefsky, J. (2007). Human papillomavirus infection in HIV-infected persons. Topics in HIV medicine: a publication of the International AIDS Society, USA 15, 130-133.<br>Pantanowitz, L., & Michelow, P. (2011). Review of human immunodeficiency virus (HIV) and squamous lesions of the uterine cervix. Diagnostic Cytopathology, 39(1), 65–72. <a href="https://doi.org/10.1002/dc.21364">https://doi.org/10.1002/dc.21364</a></li>
<li>Patel, S., & Chiplunkar, S. (2009). Host immune responses to cervical cancer. Current Opinion in Obstetrics & Gynecology, 21(1), 54–59. <a href="https://doi.org/10.1097/GCO.0b013e32831a9890">https://doi.org/10.1097/GCO.0b013e32831a9890</a></li>
<li>Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016). Global burden of cancers attributable to infections in 2012: A synthetic analysis. The Lancet. Global Health, 4(9), e609–e616. <a href="https://doi.org/10.1016/S2214-109X(16)30143-7">https://doi.org/10.1016/S2214-109X(16)30143-7</a></li>
<li>Plummer, M., Herrero, R., Franceschi, S., Meijer, C. J., Snijders, P., Bosch, F. X., . . . Muñoz, N. (2003). Smoking and cervical cancer: Pooled analysis of the IARC multi-centric case–control study. Cancer Causes & Control, 14(9), 805–814. <a href="https://doi.org/10.1023/B:CACO.0000003811.98261.3e">https://doi.org/10.1023/B:CACO.0000003811.98261.3e</a></li>
<li>Poorolajal, J., & Jenabi, E. (2016). The association between BMI and cervical cancer risk: A meta-analysis. European Journal of Cancer Prevention, 25(3), 232–238. <a href="https://doi.org/10.1097/CEJ.0000000000000164">https://doi.org/10.1097/CEJ.0000000000000164</a></li>
<li>Rader, J. S. (2009). Host and viral genetics and risk of cervical cancer. In The Role of Genetics in Breast and Reproductive Cancers (pp. 263–284). Springer. <a href="https://doi.org/10.1007/978-1-4419-0477-5_12">https://doi.org/10.1007/978-1-4419-0477-5_12</a></li>
<li>Rossi, P. G., Baldacchini, F., & Ronco, G. (2014). The possible effects on socio-economic inequalities of introducing HPV testing as primary test in cervical cancer screening programs. Frontiers in Oncology, •••, 4.</li>
<li>Roura, E., Castellsagué, X., Pawlita, M., Travier, N., Waterboer, T., Margall, N., . . . Gram, I. T. (2014). Smoking as a major risk factor for cervical cancer and pre‐cancer: Results from the EPIC cohort. International Journal of Cancer, 135(2), 453–466. <a href="https://doi.org/10.1002/ijc.28666">https://doi.org/10.1002/ijc.28666</a></li>
<li>Siddiqui, M. A. A., & Perry, C. M. (2006). Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil®). Drugs, 66(9), 1263–1271. <a href="https://doi.org/10.2165/00003495-200666090-00008">https://doi.org/10.2165/00003495-200666090-00008</a></li>
<li>Siegel, E. M., Salemi, J. L., Villa, L. L., Ferenczy, A., Franco, E. L., & Giuliano, A. R. (2010). Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecologic Oncology, 118(3), 289–294. <a href="https://doi.org/10.1016/j.ygyno.2010.05.022">https://doi.org/10.1016/j.ygyno.2010.05.022</a></li>
<li>Silva, J., Cerqueira, F., & Medeiros, R. (2014). Chlamydia trachomatis infection: Implications for HPV status and cervical cancer. Archives of Gynecology and Obstetrics, 289(4), 715–723. <a href="https://doi.org/10.1007/s00404-013-3122-3">https://doi.org/10.1007/s00404-013-3122-3</a></li>
<li>Simon, T. A., Thompson, A., Gandhi, K. K., Hochberg, M. C., & Suissa, S. (2015). Incidence of malignancy in adult patients with rheumatoid arthritis: A meta-analysis. Arthritis Research & Therapy, 17(1), 212. <a href="https://doi.org/10.1186/s13075-015-0728-9">https://doi.org/10.1186/s13075-015-0728-9</a></li>
<li>Smith, J. S., Bosetti, C., Muñoz, N., Herrero, R., Bosch, F. X., Eluf-Neto, J., . . . Peeling, R. W. (2004). Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case‐control study. International Journal of Cancer, 111(3), 431–439. <a href="https://doi.org/10.1002/ijc.20257">https://doi.org/10.1002/ijc.20257</a></li>
<li>Smith, J. S., Herrero, R., Bosetti, C., Munoz, N., Bosch, F. X., Eluf-Neto, J., . . . Franceschi, S. (2002). Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. Journal of the National Cancer Institute, 94(21), 1604–1613. <a href="https://doi.org/10.1093/jnci/94.21.1604">https://doi.org/10.1093/jnci/94.21.1604</a></li>
<li>Tomita, L. Y., Costa, M. C., Andreoli, M. A. A., Villa, L. L., Franco, E. L., & Cardoso, M. A. (2010). Diet and serum micronutrients in relation to cervical neoplasia and cancer among low‐income Brazilian women. International Journal of Cancer, 126(3), 703–714. <a href="https://doi.org/10.1002/ijc.24793">https://doi.org/10.1002/ijc.24793</a></li>
<li>Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017). Global cancer in women: burden and trends. AACR.</li>
<li>Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016). Global cancer incidence and mortality rates and trends—An update. Cancer Epidemiology and Prevention Biomarkers, 25(1), 16–27. <a href="https://doi.org/10.1158/1055-9965.EPI-15-0578">https://doi.org/10.1158/1055-9965.EPI-15-0578</a></li>
<li>Ueda, K., Kawachi, I., & Tsukuma, H. (2006). Cervical and corpus cancer survival disparities by socioeconomic status in a metropolitan area of Japan. Cancer Science, 97(4), 283–291. <a href="https://doi.org/10.1111/j.1349-7006.2006.00179.x">https://doi.org/10.1111/j.1349-7006.2006.00179.x</a></li>
<li>Vaccarella, S., Laversanne, M., Ferlay, J., & Bray, F. (2017). Cervical cancer in Africa, Latin America and the Caribbean, and Asia: Regional inequalities and changing trends. International Journal of Cancer, 141(10), 1997–2001. <a href="https://doi.org/10.1002/ijc.30901">https://doi.org/10.1002/ijc.30901</a></li>
<li>Vaccarella, S., Lortet-Tieulent, J., Plummer, M., Franceschi, S., & Bray, F. (2013). Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors. European Journal of Cancer, 49(15), 3262–3273. <a href="https://doi.org/10.1016/j.ejca.2013.04.024">https://doi.org/10.1016/j.ejca.2013.04.024</a></li>
<li>Vanakankovit, N., and Taneepanichskul, S. (2008). Effect of oral contraceptives on risk of cervical cancer. Medical journal of the Medical Association of Thailand 91, 7.</li>
<li>Wang, S. S., Gonzalez, P., Yu, K., Porras, C., Li, Q., Safaeian, M., . . . Schiffman, M. (2010). Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One, 5(1), e8667. <a href="https://doi.org/10.1371/journal.pone.0008667">https://doi.org/10.1371/journal.pone.0008667</a></li>
<li>Wardak, S. (2016). Human Papillomavirus (HPV) and cervical cancer. Medycyna Doswiadczalna i Mikrobiologia, 68, 73.</li>
<li>Wee, C. C., McCarthy, E. P., Davis, R. B., & Phillips, R. S. (2000). Screening for cervical and breast cancer: Is obesity an unrecognized barrier to preventive care? Annals of Internal Medicine, 132(9), 697–704. <a href="https://doi.org/10.7326/0003-4819-132-9-200005020-00003">https://doi.org/10.7326/0003-4819-132-9-200005020-00003</a></li>
<li>Wigle, J., Coast, E., & Watson-Jones, D. (2013). Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine, 31(37), 3811–3817. <a href="https://doi.org/10.1016/j.vaccine.2013.06.016">https://doi.org/10.1016/j.vaccine.2013.06.016</a></li>
<li>Zur Hausen, H. (2002). Papillomaviruses and cancer: From basic studies to clinical application. Nature Reviews. Cancer, 2(5), 342–350. <a href="https://doi.org/10.1038/nrc798">https://doi.org/10.1038/nrc798</a></li>
</ol>
Downloads
Published
2017-12-08
Issue
Section
Review
License
Copyright The Author(s) 2017. This article is published with open access by BioMedPress. This article is distributed under the terms of the Creative Commons Attribution License (CC-BY 4.0) which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
How to Cite
Incidence, mortality and risk factors of cervical cancer in the world. (2017). Biomedical Research and Therapy, 4(12), 1795-1811. https://doi.org/10.15419/bmrat.v4i12.386
